Ahead of its earnings report on October 13, UnitedHealth Group is experiencing a notable increase in implied volatility, which is currently twice the realized volatility. This suggests that options prices are elevated, creating opportunities for traders to implement short premium strategies.
Specifically, traders can sell November options to reduce the cost of a longer-dated January call significantly. Despite challenges such as rising healthcare costs and a potential decline in ACA marketplace enrollment, UnitedHealth's management has set an achievable EPS growth target of 13% to 16%.
The company covers approximately 12% to 13.5% of the U.S. population, with growth in its commercial and Medicare segments, although the commercial segment's growth appears modest compared to the overall workforce increase. The stock is currently trading at 17 times forward earnings, with free cash flow representing 5.7% of enterprise value.
The options market is implying a 40% volatility for the stock, reflecting the potential for significant price movement following earnings, especially given its history of sharp declines post-earnings.
The suggested trading strategy involves selling a strangle to finance the purchase of a January 2027 call, which could provide a favorable risk-reward scenario if the stock remains within a specified range. Overall, the market's reaction to UnitedHealth's earnings report will be closely watched, particularly in light of its recent performance and the broader healthcare sector dynamics